Abstract:OBJECTIVES:Findings from prior investigations show that left stellate ganglion (LSG) inhibitory approaches protect the heart from ventricular arrhythmias (VAs) caused by acute myocardial infarction (AMI), which still remain many side effects. Targeted transient receptor potential vanilloid 1/tyrosine hydroxylase (TRPV-1/TH) expressing sympathetic neurons ablation is a novel neuro-ablative strategy. The aim of this investigation was to explore if targeted molecular neuro-ablative strategy by resiniferatoxin (RTX) stellate microinjection could protect against ischemia-induced VAs.METHODS:Twenty-four anesthetized beagles were assigned to a control group (n = 12) and RTX group (n = 12) in a random manner. Targeted molecular neuro-ablative was produced by RTX stellate microinjection and DMSO was microinjected into LSG in the same way as control. Plasma norepinephrine (NE) level, heart rate variability (HRV), Tpeak-Tend interval (Tp-Te), LSG neural activity and function, ventricular effective refractory period (ERP), beat-to-beat variability of repolarization (BVR) and ventricular action potential duration (APD) were measured at baseline and 60 min after RTX or DMSO microinjection. AMI model was established by the ligation of left anterior descending coronary artery and 60-minute electrocardiography was continuously recorded for VAs analysis. Subsequently, HRV, Tp-Te, plasma NE level from jugular vein and coronary sinus, LSG neural activity and function, ventricular ERP, ventricular APD, BVR, action potential duration alternans (APDA) cycle length and ventricular fibrillation threshold (VFT) were evaluated after AMI. Finally, tissue collection of LSG was performed for examining the TRPV-1, nerve growth factor (NGF) protein and c-fos protein.RESULTS:TRPV-1 was highly expressed in the TH-expressing neurons and RTX injection significantly ablated TRPV-1/TH-positive neurons in LSG. Compared with baseline, RTX stellate microinjection significantly reduced plasma NE level, the sympathetic component of HRV, LSG neural activity and LSG function, shortened Tp-Te, prolonged ventricular ERP and APD, but there were no remarkable differences existed for control group. AMI resulted in the significant raise in plasma NE level from jugular vein and coronary sinus, the sympathetic component of HRV, LSG neural activity and LSG function, the marked prolongation in Tp-Te and BVR, the significant decrease in ERP and APD from ischemia area, and the increase in APDA cycle length in the ischemic region of the control group, which were remarkably attenuated in the RTX group. RTX pretreatment markedly rose the VFT in the RTX group. Furthermore, the AMI-triggered VAs was significantly prevented by RTX injection in the RTX group. RTX microinjection down-regulated significantly TRPV-1, NGF and c-fos expression in the LSG compared with the control group.CONCLUSION:Targeted ablation of TRPV-1/TH positive sympathetic neurons induced by RTX stellate microinjection could suppress ischemia-induced cardiac autonomic imbalances and cardiac electrophysiology instability to protect against AMI-induced VAs.

Optogenetic Modulation of Cardiac Sympathetic Nerve Activity to Prevent Ventricular Arrhythmias

Optogenetic Approach Modulates Cardiac Sympathetic Ganglion to Protect Against Ischemia Related Ventricular Arrhythmias

Prevention and Reversal of Atrial Fibrillation Inducibility and Autonomic Remodeling by Low-Level Vagosympathetic Nerve Stimulation.

Abstract 4142818: Odorgenetics-based Noninvasive and Precise Neuromodulation of Cardiac Ganglia Plexus Prevents Myocardial Ischemia-Induced Ventricular Arrhythmia

CHRONIC OPTOGENETIC INHIBITION OF CARDIAC SYMPATHETIC NERVE ACTIVITY REDUCES CARDIAC REMODELING AND VENTRICULAR ARRHYTHMIA INDUCIBILITY IN A POST-INFARCTION CANINE MODEL

Selective Chemical Ablation of Transient Receptor Potential Vanilloid 1 Expressing Neurons in the Left Stellate Ganglion Protects Against Ischemia-Induced Ventricular Arrhythmias in Dogs.

Precise Modulation of Gold Nanorods for Protecting Against Malignant Ventricular Arrhythmias Via Near‐Infrared Neuromodulation

Optogenetic Therapy on Cardiac Vagal Dysfunction-Related Ventricular Arrhythmia in Type 2 Diabetes

Cardiac Sympathetic Afferent Denervation Protects Against Ventricular Arrhythmias by Modulating Cardiac Sympathetic Nerve Activity During Acute Myocardial Infarction

Blocking the Nav1.8 channel in the left stellate ganglion suppresses ventricular arrhythmia induced by acute ischemia in a canine model

Low-Level Vagus Nerve Stimulation Attenuates Myocardial Ischemic Reperfusion Injury by Antioxidative Stress and Antiapoptosis Reactions in Canines.

Left Stellate Ganglion Ablation Inhibits Ventricular Arrhythmias Through Macrophage Regulation in Canines with Acute Ischemic Stroke

Wireless Self‐Powered Optogenetic System for Long‐Term Cardiac Neuromodulation to Improve Post‐MI Cardiac Remodeling and Malignant Arrhythmia

Anti-arrhythmic Effects of Atrial Ganglionated Plexi Stimulation is Accompanied by Preservation of Connexin43 Protein in Ischemia-Reperfusion Canine Model.

Light-emitting diode therapy protects against ventricular arrhythmias by neuro-immune modulation in myocardial ischemia and reperfusion rat model

Abstract 11392: Chronic Low-Level Transcutaneous Electrical Stimulation of the Auricular Branch of the Vagus Nerve: A New Approach to Attenuate Neural Remodeling and Reduce Ventricular Arrhythmias in a Post-Infarction Canine Model

Chronic Intermittent Low-Level Stimulation of Tragus Reduces Cardiac Autonomic Remodeling and Ventricular Arrhythmia Inducibility in a Post-Infarction Canine Model

Spinal Cord Stimulation Protects Against Ventricular Arrhythmias by Suppressing Left Stellate Ganglion Neural Activity in an Acute Myocardial Infarction Canine Model.

Noninvasive LED therapy: A novel approach for post-infarction ventricular arrhythmias and neuro-immune modulation.

Selective Ablation Of The Ligament Of Marshall Reduces Ischemia And Reperfusion-Induced Ventricular Arrhythmias

Optogenetic Approaches for Termination of Ventricular Tachyarrhythmias after Myocardial Infarction in Rats in Vivo.